Instil Bio, Inc. (TIL) income statement
TILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$5.55+0.12 (+2.21%)
Close on Nov 19, 2026Market cap $37.64MP/E –Yield –
Instil Bio, Inc. financial ratios
See a number that looks wrong?